What is Stryker Corporation share price today?

Stryker Corporation (SYK) share price today is {{live_price}}.

Can Indians buy Stryker Corporation shares?

Yes, Indians can invest in the Stryker Corporation (SYK) from India. With INDmoney, you can buy Stryker Corporation at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Stryker Corporation at zero transaction cost.

How can I buy Stryker Corporation shares from India?

It is very easy to buy Stryker Corporation from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Stryker Corporation be purchased?

Yes, you can buy fractional shares of Stryker Corporation with INDmoney app.

What are the documents required to start investing in Stryker Corporation stocks?

To start investing in Stryker Corporation, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Stryker Corporation

Today’s highest price of Stryker Corporation (SYK) is {{1_rba_end}}. Today’s lowest price of Stryker Corporation (SYK) is {{1_rba_st}}.

What is today's market capitalisation of Stryker Corporation

Today's market capitalisation of Stryker Corporation SYK is 137.7B

What is the 52 Week High and Low Range of Stryker Corporation

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Stryker Corporation is down from its 52 Week High?

Stryker Corporation (SYK) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Stryker Corporation is up from its 52 Week low?

Stryker Corporation (SYK) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Stryker Corporation?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Stryker Corporation

Mr. Kevin A. Lobo is the current Chief Executive Officer (CEO) of Stryker Corporation.

Home>
US Stocks>
Stryker Corporation

Stryker Corporation (SYK)

$355.11

-2.16

(-0.6%)▲

Market is closed - opens 7 PM, 03 Oct 2024

Stryker Corporation is a medical technology company that develops and manufactures innovative products for orthopedics, spine, and neurotechnology.

Performance

$351.93
$356.85
$355.11
0.9%
Downside
Day's Volatility :1.38%
Upside
0.49%
$249.98
$374.63
$355.11
29.6%
Downside
52 Weeks Volatility :33.27%
Upside
5.21%

Returns

Period	Stryker Corporation	Sector (Health Care)	S&P500
3 Months	8.81%	7.5%	3.1%
6 Months	2.92%	6.9%	9.6%
1 Year	35.88%	20.9%	35.0%
3 Years	37.71%	21.0%	31.0%

Highlights

Market Capitalization	137.7B
Book Value	$51.86
Dividend Share	3.15
Dividend Yield	0.89%
Earnings Per Share (EPS)	8.97
PE Ratio	40.27
PEG Ratio	2.65
Wall Street Target Price	377.65

Profit Margin	16.12%
Operating Margin TTM	21.19%

Return On Assets TTM	7.24%
Return On Equity TTM	18.58%

Revenue TTM	21.4B
Revenue Per Share TTM	56.25
Quarterly Revenue Growth YOY	8.5%
Gross Profit TTM	11.6B
EBITDA	5.5B
Diluted Eps TTM	8.97
Quarterly Earnings Growth YOY	0.11

EPS Estimate Current Year	12.0
EPS Estimate Next Year	13.49
EPS Estimate Current Quarter	2.79
EPS Estimate Next Quarter	2.79

Analyst Recommendation

Buy

67%Buy

32%Hold

0%Sell

Based on 34 Wall street analysts offering stock ratings for Stryker Corporation(by analysts ranked 0 to 5 stars)

Based on 34 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 6.35%

Current $355.11

Target $377.65

Company Financials

	FY18	Y/Y Change
Revenue	13.6B	↑ 9.3%
Net Income	3.6B	↑ 248.33%
Net Profit Margin	26.12%	↑ 17.92%

	FY19	Y/Y Change
Revenue	14.9B	↑ 9.43%
Net Income	2.1B	↓ 41.37%
Net Profit Margin	13.99%	↓ 12.13%

	FY20	Y/Y Change
Revenue	14.4B	↓ 3.58%
Net Income	1.6B	↓ 23.24%
Net Profit Margin	11.14%	↓ 2.85%

	FY21	Y/Y Change
Revenue	17.1B	↑ 19.21%
Net Income	2.0B	↑ 24.7%
Net Profit Margin	11.66%	↑ 0.52%

	FY22	Y/Y Change
Revenue	18.4B	↑ 7.84%
Net Income	2.4B	↑ 18.25%
Net Profit Margin	12.78%	↑ 1.12%

	FY23	Y/Y Change
Revenue	20.5B	↑ 11.11%
Net Income	3.2B	↑ 34.22%
Net Profit Margin	15.44%	↑ 2.66%

	Q1 FY23	Q/Q Change
Revenue	4.8B	↓ 8.15%
Net Income	592.0M	↑ 5.15%
Net Profit Margin	12.39%	↑ 1.57%

	Q2 FY23	Q/Q Change
Revenue	5.0B	↑ 4.56%
Net Income	738.0M	↑ 24.66%
Net Profit Margin	14.77%	↑ 2.38%

	Q3 FY23	Q/Q Change
Revenue	4.9B	↓ 1.74%
Net Income	692.0M	↓ 6.23%
Net Profit Margin	14.1%	↓ 0.67%

	Q4 FY23	Q/Q Change
Revenue	5.8B	↑ 18.46%
Net Income	1.1B	↑ 65.17%
Net Profit Margin	19.66%	↑ 5.56%

	Q1 FY24	Q/Q Change
Revenue	5.2B	↓ 9.84%
Net Income	788.0M	↓ 31.06%
Net Profit Margin	15.03%	↓ 4.63%

	Q2 FY24	Q/Q Change
Revenue	5.4B	↑ 3.41%
Net Income	825.0M	↑ 4.7%
Net Profit Margin	15.22%	↑ 0.19%

	FY18	Y/Y Change
Total Assets	27.2B	↑ 22.75%
Total Liabilities	15.5B	↑ 27.16%

	FY19	Y/Y Change
Total Assets	30.2B	↑ 10.79%
Total Liabilities	17.4B	↑ 12.01%

	FY20	Y/Y Change
Total Assets	34.3B	↑ 13.8%
Total Liabilities	21.2B	↑ 22.38%

	FY21	Y/Y Change
Total Assets	34.6B	↑ 0.88%
Total Liabilities	19.8B	↓ 7.02%

	FY22	Y/Y Change
Total Assets	36.9B	↑ 6.51%
Total Liabilities	20.3B	↑ 2.6%

	FY23	Y/Y Change
Total Assets	39.9B	↑ 8.21%
Total Liabilities	21.3B	↑ 5.19%

	Q1 FY23	Q/Q Change
Total Assets	36.8B	↓ 0.15%
Total Liabilities	19.9B	↓ 1.64%

	Q2 FY23	Q/Q Change
Total Assets	37.4B	↑ 1.57%
Total Liabilities	20.0B	↑ 0.57%

	Q3 FY23	Q/Q Change
Total Assets	38.0B	↑ 1.69%
Total Liabilities	20.1B	↑ 0.44%

	Q4 FY23	Q/Q Change
Total Assets	39.9B	↑ 4.92%
Total Liabilities	21.3B	↑ 5.87%

	Q1 FY24	Q/Q Change
Total Assets	39.4B	↓ 1.28%
Total Liabilities	20.2B	↓ 5.11%

	Q2 FY24	Q/Q Change
Total Assets	39.1B	↓ 0.69%
Total Liabilities	19.4B	↓ 4.26%

	FY18	Y/Y Change
Operating Cash Flow	2.6B	↑ 67.42%
Investing Cash Flow	-2.9B	↑ 77.12%
Financing Cash Flow	1.3B	↓ 267.38%

	FY19	Y/Y Change
Operating Cash Flow	2.2B	↓ 16.05%
Investing Cash Flow	-1.5B	↓ 49.07%
Financing Cash Flow	3.0M	↓ 99.77%

	FY20	Y/Y Change
Operating Cash Flow	3.3B	↑ 49.57%
Investing Cash Flow	-4.7B	↑ 223.09%
Financing Cash Flow	-11.0M	↓ 466.67%

	FY21	Y/Y Change
Operating Cash Flow	3.3B	↓ 0.43%
Investing Cash Flow	-859.0M	↓ 81.73%
Financing Cash Flow	-2.4B	↑ 21400.0%

	FY22	Y/Y Change
Operating Cash Flow	2.6B	↓ 19.58%
Investing Cash Flow	-2.9B	↑ 240.4%
Financing Cash Flow	-749.0M	↓ 68.33%

	Q1 FY23	Q/Q Change
Operating Cash Flow	445.0M	↓ 55.63%
Investing Cash Flow	-132.0M	↓ 95.49%
Financing Cash Flow	-481.0M	↑ 7.85%

	Q2 FY23	Q/Q Change
Operating Cash Flow	688.0M	↑ 54.61%
Investing Cash Flow	-533.0M	↑ 303.79%
Financing Cash Flow	-405.0M	↓ 15.8%

	Q3 FY23	Q/Q Change
Operating Cash Flow	1.1B	↑ 52.62%
Investing Cash Flow	-810.0M	↑ 51.97%
Financing Cash Flow	-422.0M	↑ 4.2%

Technicals Summary

Sell

Neutral

Buy

Stryker Corporation is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Stryker Corporation	0.46%	2.92%	35.88%	37.71%	69.5%
Edwards Lifesciences Corp.	-4.01%	-29.06%	-5.19%	-37.96%	-11.22%
Medtronic Plc	1.2%	5.92%	17.62%	-28.0%	-15.8%
Boston Scientific Corp.	3.28%	23.0%	62.59%	97.59%	110.82%
Abbott Laboratories	-0.57%	2.45%	19.02%	-1.32%	40.63%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Stryker Corporation	40.27	40.27	2.65	12.0	0.19	0.07	0.01	51.86
Edwards Lifesciences Corp.	25.98	25.98	3.51	2.63	0.22	0.12	NA	12.35
Medtronic Plc	30.31	30.31	1.67	5.2	0.08	0.04	0.03	37.39
Boston Scientific Corp.	68.13	68.13	2.06	2.41	0.09	0.05	NA	13.85
Abbott Laboratories	35.41	35.41	4.16	4.66	0.14	0.06	0.02	22.6

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Stryker Corporation	Buy	$137.7B	69.5%	40.27	16.12%
Edwards Lifesciences Corp.	Buy	$40.1B	-11.22%	25.98	23.74%
Medtronic Plc	Buy	$115.5B	-15.8%	30.31	12.06%
Boston Scientific Corp.	Buy	$123.4B	110.82%	68.13	12.0%
Abbott Laboratories	Buy	$198.4B	40.63%	35.41	13.65%

Insights on Stryker Corporation

Increasing Revenue
Revenue is up for the last 2 quarters, 5.24B → 5.42B (in $), with an average increase of 3.3% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, 788.0M → 825.0M (in $), with an average increase of 4.5% per quarter
Vs BSX
In the last 1 year, Boston Scientific Corp. has given 62.6% return, outperforming this stock by 26.7%
Vs BSX
In the last 3 years, Boston Scientific Corp. has given 91.3% return, outperforming this stock by 56.6%

Institutional Holdings

Vanguard Group Inc
8.41%
BlackRock Inc
7.03%
Greenleaf Trust
4.87%
State Street Corp
3.74%
T. Rowe Price Associates, Inc.
3.07%
Wellington Management Company LLP
2.95%

Corporate Announcements

Stryker Corporation Dividends March,2024
In the quarter ending March,2024. Stryker Corporation has declared dividend of $0.8
Read More

Organization	Stryker Corporation
Employees	52000
CEO	Mr. Kevin A. Lobo
Industry	Health Technology

Stryker Corporation (SYK)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Increasing Revenue

Increasing Net Profit

Vs BSX

Vs BSX

Institutional Holdings

Corporate Announcements

Stryker Corporation Dividends March,2024

Company Information

Discover More

FAQs